نتایج جستجو برای: neoadjuvant chemotherapy

تعداد نتایج: 120769  

2011
Batuhan Özmen Yavuz Emre Şükür Cem Somer Atabekoglu Aylin Okçu Heper Murat Sönmezer Mete Güngör

Port-site metastases in gynecological malignancies subsequent to laparoscopy have been reported with an incidence of 1.1-16%. These metastases tend to be disappearing after primary debulking surgery and subsequent primary chemotherapy. Local resection, chemotherapy and/or radiotherapy have been defined in the management of these metastases with enhanced clinical success. However, in extremely r...

2013
Daniel Guimarães Tiezzi Willian Simões Clagnan Larissa Raquel Mouro Mandarano Christiani Bisinoto de Sousa Heitor Ricardo Cosiski Marana Marcelo Guimarães Tiezzi Jurandyr Moreira de Andrade

OBJECTIVE To analyze the expression of hypoxia-inducible factors (hypoxia-inducible factor 1A and hypoxia-inducible factor 2A) and aldehyde dehydrogenase proteins in patients with locally advanced breast carcinoma who were subjected to neoadjuvant chemotherapy. METHODS We included 90 patients with histologically confirmed stage II and III breast carcinoma who were treated with neoadjuvant che...

2013
Nobuaki Matsubara Hirofumi Mukai Yoichi Naito Masahiko Nezu Kuniaki Itoh

AIM Radical cystectomy plus platinum-based perioperative chemotherapy is a standard treatment for patients with clinically localized muscle-invasive bladder cancer. The standard perioperative chemotherapy is methotrexate, vinblastine, doxorubicin and cisplatin (MVAC). However, no prospective randomized trial has been published that compares neoadjuvant and adjuvant chemotherapy for bladder canc...

Journal: :The British journal of surgery 2016
F Klevebro M Lindblad J Johansson L Lundell M Nilsson

BACKGROUND Randomized trials have shown that neoadjuvant treatment improves survival in the curative treatment of oesophageal and gastro-oesophageal junction cancer. Results from population-based observational studies are, however, sparse and ambiguous. METHODS This prospective population-based cohort study included all patients who had oesophagectomy for cancer in Sweden, excluding clinical ...

Journal: :Onkologie 2003
R Tiling M Kessler M Untch H Sommer R Linke K Brinkbäumer K Hahn

BACKGROUND Aim of the study was to assess the value of scintimammography using Tc-99m sestamibi in the evaluation of tumor response to neoadjuvant chemotherapy. MATERIAL ANS METHODS: Results were calculated for 9 patients undergoing neoadjuvant chemotherapy. Scintimammography using 740 MBq Tc-99m sestamibi was performed before, during and after chemotherapy, and sestamibi uptake was scored visu...

2003
RKC Ngan

The addition of adjuvant or neoadjuvant chemotherapy to surgery revolutionises the treatment of high-grade non-metastatic osteosarcoma of the extremities. Overall 5-year survival of more than 50% to 60% is now a realistic achievable goal. Neoadjuvant chemotherapy possesses the theoretical advantages of optimising surgical results, providing early treatment of micrometastases, allowing histologi...

2012
Julio A. Ibarra

Historically, neoadjuvant chemotherapy has been used to treat patients with advanced breast disease in an attempt to convert them into candidates for breast conservation surgery. The ultimate goal of histopathologic examination of the specimens removed after neoadjuvant chemotherapy is the identification of either residual disease or positive identification of the tumor bed. We report a series ...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2010
Samina Khokher Saqib Mahmood Saeed Akhtar Khan

A large proportion of women present with advanced breast cancer in the developing countries with limited resources. Many of these patients have ulcerated, bleeding lesions or visually obvious masses in the breast. Neoadjuvant chemotherapy is well established as the standard of care and initial management of choice for these patients. Tumor shrinkage achieved with neoadjuvant chemotherapy has th...

Journal: :Experimental oncology 2013
A Eroğlu F Aydin

In non-inflammatory locally advanced breast cancer, treatment typically includes neoadjuvant chemotherapy, surgery, and radiation therapy. Neoadjuvant chemotherapy allows in vivo assessment of primary tumor response to chemotherapy and is achieved the early control of micrometastatic disease. It also significantly improves surgical outcomes. Patients achieving pathologic complete response after...

2015
Min Kyu Kang Dongryul Oh Kwan Ho Cho Sung Ho Moon Hong-Gyun Wu Dae-Seog Heo Yong Chan Ahn Keunchil Park Hyo Jung Park Jun Su Park Ki Chang Keum Jihye Cha Jun Won Kim Yeon-Sil Kim Jin Hyoung Kang Young-Taek Oh Ji-Yoon Kim Sung Hwan Kim Jin-Hee Kim Chang Geol Lee

PURPOSE To define the role of neoadjuvant and concurrent chemotherapy in stage II nasopharyngeal carcinoma, we compared the treatment outcomes of patients treated with curative radiotherapy with or without chemotherapy. MATERIALS AND METHODS From 2004 to 2011, 138 patients with American Joint Committee on Cancer (AJCC) 2002 stage II nasopharyngeal carcinoma were treated with curative radiothe...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید